Carlos N. Velez
Chief Executive Officer presso Lacerta Bio, Inc.
Profilo
Carlos N.
Velez is the founder of Lacerta Bio, Inc. (founded in 2010) and Connexin Therapeutics Ltd (founded in 2018), where he holds the title of Chief Executive Officer.
Currently, he is the Director of Business Development at Panion Animal Health AB.
Previously, he worked as the Director of Business Development at Penwest Pharmaceuticals Co. Dr. Velez's education includes an undergraduate degree from Albany College of Pharmacy & Health Sciences, an MBA from Rochester Institute of Technology, and a doctorate from The University of North Carolina at Charlotte.
Posizioni attive di Carlos N. Velez
Società | Posizione | Inizio |
---|---|---|
Lacerta Bio, Inc.
Lacerta Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Lacerta Bio, Inc. operates as a pharmaceutical business development consultancy that specializes in identifying, assessing, negotiating, and closing licensing and partnership opportunities for pharmaceutical, biotechnology, drug delivery, medical device, diagnostic, and other life science companies. The company was founded by Carlos N. Velez in 2010 and is headquartered in Wappingers Falls, NY. | Chief Executive Officer | 01/01/2010 |
Panion Animal Health AB
Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Corporate Officer/Principal | - |
Connexin Therapeutics Ltd
Connexin Therapeutics Ltd BiotechnologyHealth Technology Connexin Therapeutics Ltd is engaged in biotechnology services. The company was founded by Carlos N. Velez in 2018 and is headquartered in York, the United Kingdom. | Chief Executive Officer | 01/01/2018 |
Precedenti posizioni note di Carlos N. Velez
Società | Posizione | Fine |
---|---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Corporate Officer/Principal | - |
Formazione di Carlos N. Velez
Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Rochester Institute of Technology | Masters Business Admin |
The University of North Carolina at Charlotte | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Lacerta Bio, Inc.
Lacerta Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Lacerta Bio, Inc. operates as a pharmaceutical business development consultancy that specializes in identifying, assessing, negotiating, and closing licensing and partnership opportunities for pharmaceutical, biotechnology, drug delivery, medical device, diagnostic, and other life science companies. The company was founded by Carlos N. Velez in 2010 and is headquartered in Wappingers Falls, NY. | Commercial Services |
Panion Animal Health AB
Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Process Industries |
Connexin Therapeutics Ltd
Connexin Therapeutics Ltd BiotechnologyHealth Technology Connexin Therapeutics Ltd is engaged in biotechnology services. The company was founded by Carlos N. Velez in 2018 and is headquartered in York, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Carlos N. Velez